Skip to main content
. 2021 Sep 2;92(4):e2021244. doi: 10.23750/abm.v92i4.11425

Table 3.

Total doses administered in 2018-2019 (n, %) and percentage increase

Vaccine Doses admnistered in 2018-2019 (n, %) Percentage increase
Flu 102 +164%
HAV* 60 (24%) +50%
HBV* 56 (22.4%) +33.3%
HPV9 66(26.4%) (+3100%)
MenACWY 46 (18.4%) +46,5%
MenB 46 (18.4%) +46,5%
PCV13 68 (27.2%) +66,6%
PPV23 68 (27.2%) (+1600%)
Total 250 +370%

* based on immunological status we administered HAV or HBV or HAV-HBV vaccine)